Abstract Bacterial phospho-N-acetylmuramyl-pentapeptide translocase (translocase I: EC 2.7.8.13) is a key enzyme in peptidoglycan biosynthesis, and a known target of antibiotics. Here we report a new nucleoside inhibitor for translocase I, A-102395, isolated from the culture broth of the strain Amycolatopsis sp. SANK 60206. A-102395 is a new derivative of capuramycin that has the benzene with a uniquely substituted chain instead of an aminocaprolactam. A-102395 is a potent inhibitor of bacterial translocase I with IC 50 value of 11 nM, but possesses no antimicrobial activity against various strains tested.
Introduction
The need for new classes of antibiotics is growing as the emergence of antibiotics resistance continues to spread worldwide. Enzymes responsible for the biosynthesis of the peptidoglycan components of the bacterial cell wall are essential for growth, and therefore are well precedented targets for antibiotics. Among these enzymes, phospho-Nacetylmuramyl-pentapeptide translocase (translocase I) catalyzes the first membrane step of peptidoglycan biosynthesis. It transfers MurNAc-pentapetide from UDPMurNAc-pentapetide to the lipid carrier, undecaprenyl phosphate to form lipid I. There are some compounds reported as translocase I inhibitors [1] , such as mureidomycins [2] , pacidamycins [3] , napsamycins [4] , liposidomycins [5] , tunicamycin [6] , capuramycins [7ϳ13], muraymycins [14] and caprazamycins [15, 16] . They exhibit antimicrobial activity against various strains including multidrug-resistant stains, and show bactericidal activity [15, 17, 18] . Thus translocase I is an established target for the search of novel antibiotics.
In the course of our screening for bacterial translocase I inhibitors, we found inhibitory activity in the culture broth of Amycolatopsis sp. SANK 60206. In this paper, we describe the taxonomy and fermentation of the producing microorganism, isolation, physico-chemical properties, structure elucidation and biological activities of A-102395. 
Materials and Methods

Materials
were previously reported [10] .
Taxonomy of the Producing Organism
The producing strain Amycolatopsis sp. SANK 60206 was isolated from a soil sample collected in Hokkaido, Japan. The methods and media described by the International Streptomyces Project (ISP) [19] and Waksman [20] were used to determine the morphological characterizations and the physiological properties of the producing organism. The cell walls and whole-cell hydrolysates were analyzed by the methods of Hasegawa et al. [21] . Lipid characterisitic of Nocardia spp., type A was analyzed by the method of Hecht [22] . The 16S rDNA was amplified by the polymerase chain reaction using genomic DNA of the strain and sequenced. The most related sequences were searched using the BLAST algorithm in the National Center for Biotechnology Information (NCBI).
Measurement of Translocase I Inhibitory Activity
The measurement of translocase I inhibitory activity was carried out in 96-well microtitre polystyrene plate (Corning Coaster, #3694) in 100 m l containing 100 mM Tris-HCl (pH 7.5), 50 mM KCl, 25 mM MgCl 2 , 0.8% Triton X-100, 166 mM undecaprenyl phosphate and
The reaction was initiated by the addition of the enzyme (0.625ϳ2.5 mg protein). The enzyme activity was monitored by measuring the increase in fluorescence at 538 nm (excitation at 355 nm).
Antimicrobial Activities
MICs were determined by the agar dilution method using Mueller Hinton agar (Becton Dickinson and Company).
General Experimental Procedures
The various NMR spectra were obtained on a Bruker AVANCE 500 spectrometer. Methanol-d 4 and DMSO-d 6 were used as solvent and internal references. FAB-MS spectra were recorded on a JEOL JMS-700QQ mass spectrometer. Optical rotations were recorded on a JASCO DIP-370 spectropolarimeter. UV spectra were obtained on a Shimadzu UV-265FW spectrometer. Fluorescence was measured at room temperature on a fluorescence spectrophotometer, Fluoroskan Ascent (Labsystems).
Results
Taxonomy
The cell walls of the strain contained meso-diaminopimelic acid but not glycine. 
Fermentation
A loopful of a culture of strain SANK 60206 was inoculated into each of two 500-ml Erlenmeyer flasks containing 80 ml of sterilized seed medium consisting of galactose 2.0%, Bacto-Soytone (Difco) 1.0%, glycerol 1.0%, dextrin 2.0%, corn steep liquor 0.5%, sodium citrate 0.1%, Na 2 HPO 4 ·12H 2 O 0.3%, (NH 4 ) 2 SO 4 0.2%, CaCO 3 0.2% and CB-442 (NOF Co., Ltd.) 0.05%. The inoculated flasks were incubated on a rotary shaker (210 rpm) at 28°C for 3 days. The cultures were combined and then 2.0 ml aliquots of the culture were transferred into each of sixtyfour 500-ml Erlenmeyer flasks containing 80 ml of sterilized production medium consisting of the same seed medium. The inoculated flasks were incubated on a rotary shaker (210 rpm) at 28°C for 6 days. 
Isolation
The isolation procedure of A-102395 is outlined in Fig. 2 . First, 4.4 liters of the culture filtrate were adjusted to pH 3.0 with 1 M HCl and adsorbed onto a DIAION SP207 column (700 ml). The column was washed with water and active substance was eluted with 10% Me 2 CO (4 liters) fractionated into 20 ml portions. The combined active fraction was concentrated in vacuo to remove Me 2 CO (2 liters) and adjusted to pH 7.0 with 1 M NaOH and adsorbed onto a Dowex 1ϫ2 column (50 ml). The column was washed with water and the active substance was successively eluted with 0.02 M HCl (500 ml) and 0.05 M HCl (500 ml) and fractionated in 20 ml portions. Active fractions were collected, adjusted to pH 3.0 with 1 M NaOH, subjected to SP207 column (8 ml). After the column was washed with water, active substance was eluted with MeOH and concentrated in vacuo to give 492 mg of brown powder. The powder was dissolved in 0.5% triethylamine phosphate (TEAP) aq. (pH 3.0, 2.5 ml) and applied onto a Cosmosil column (50 ml). The column was washed with 0.5% TEAP aq. (pH 3.0, 250 ml) and active substance was eluted with 5.0% MeOH -0.5% TEAP aq.
(pH 3.0, 500 ml). The active fractions were collected, concentrated in vacuo to remove MeOH and subjected on SP207 column (8 ml [24] and HMBC [25] experiments clarified that the partial structure A of A-102395 (Fig. 3 ) was identical to that of capuramycin and A500359s [9] . Further analysis of the additional correlations of the signals revealed the partial structure B and C as follows. The 1 H-13 C long range couplings of 2 J and 3 J observed in the HMBC experiment gave the following information. The cross peaks from H-2a and H-6a to C-1a and C-4a, and from H-3a and H-5a to C-1a and C-4a as well as the coupling constant (8.5 Hz) obsearved between H-2a/H-6a and H-3a/H-5a suggested the presence of a 1,4-disubstituted benzene. The cross peaks from H-8a to C-9a elucidated the structure from C-7a to C-9a. The cross peaks from H-7a to C-3a and C-5a, and from H-8a to C-4a elucidated the connection between C-7a and benzene in the partial structure B. The cross peaks from H-2b to C-3b and from H-1c to C-3b and C-2c revealed the partial structure C from C-1b to C-2c. The geometrical configuration of the double bond at C1b-C2b proved to be E based on J H1b-H2b (14.0 Hz). To determine the linkages between the three partial structures, a series of NMR experiments were performed again using DMSO-d 6 From its molecular formula, two carbonyl residues, C-6Ј and C-2c, were expected to form amide or carboxylate group. To determine which carbon formed carboxylate group, A-102395 was converted to the methyl ester derivative by TMS-diazomethane. In HMBC experiment of this derivative (using methanol-d 4 as solvent), the long range coupling from d H 3.72 of methoxy proton to C-2c was observed. It was proved that C-2c formed carboxylate group and C-6Ј formed amide group. The planer structure of A-102395 was concluded to be as shown in Fig. 1 .
Biological Activities of A-102395
A-102395 inhibited translocase I with IC 50 value of 11 nM, but did not show any antimicrobial activity against Grampositive and -negative bacteria tested. [10] . In the previous studies of capuramycin and A-500359s [10, 11] , we revealed the core skeleton (2Ј-methoxyuridine attached an unsaturated uronic acid moiety) was necessary for the inhibition of translocase I. Compared with the structure of A-102395, the core skeleton (partial structure A) is the same as of capuramycin, but A-102395 has the benzene with a uniquely substituted chain instead of an aminocaprolactam. So, it is considered that the potency of the inhibition of translocase I by A-102395 basically comes from the core skeleton, and the other structural features may influence the activity. A-102395 had potent inhibitory activity for bacterial translocase I, but lacked antimicrobial activity against various strains tested. In the previous studies, it revealed capuramycin and A-500359s showed antimicrobial activities against S. pneumoniae and Mycobacterium. We think A-102395 has the potency for antimicrobial activity, but the poor permeability of the bacterial membrane may cause the lack of the antimicrobial activity. There are some compounds reported as translocase I inhibitors. Most of them are also natural products containing a nucleoside moiety and have unique spectra of antimicrobial activity. Mureidomycins, pacidamycins and napsamycins are closely related compounds containing a 3Ј-deoxyuridine attached a peptide chain, and active against Pseudomonas strains. Liposidomycins and caprazamycins are uridine compounds containing a diazepine, and an acyl moiety. They have potent antimicrobial activity against Mycobacterium. These limited spectra of antimicrobial activity also may be due to a permeability of the bacterial membrane. In the recent reports, some of synthesized analogues of pacidamycins [26] , liposidomycins [27] , capuramycin [28, 29] and caprazamycins [30, 31] showed broader spectrum and more potent antimicrobial activity. So, there is possibility that some chemical modification of A-102395 at the C-2c or the chain attached to benzene may improve the antimicrobial activity.
Previously, we discovered capuramycin related compounds, A-500359s and A-503083 [32] . Though these producing strains were classified into Streptomyces sp., the producing strain of A-102395 is distinct from them taxonomically. It is interesting to note that strains belong to different families of actinomycetes produce similar compounds. It is possible that both of producing organisms share common biosynthetic genes and synthesize the core skeleton of capuramycin via the identical biosynthetic pathway. Therefore, these producing organisms may be useful to study for biosynthesis of capuamycin.
